In MMTV-ErbB2/neu and MMTV-PyMTV models, Maroulakou et al. 26 reported that AKT1 ablation delays tumor formation, but has no effect on metastasis, whereas AKT2 ablation enhances mammary tumor growth. The gene discussed is AKT2; the disease is breast cancer.